San Diego-dependent Viking Therapeutics marked by itself as a significant competitor during the weight loss drug market in February right after revealing promising facts from the mid-stage trial of experimental drug VK2735, which proposed it rivaled—and outperformed—Novo and Lilly drugs when offered like a weekly injection As well as in March t